Max Healthcare Institute

Max Healthcare Institute

1,137.90
+7.20
(0.64%)
ann
There are new updates from the company17 hours ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
1,10,630.78 Cr
EPS
11.07
PE Ratio
92.29
Dividend Yield
0.13 %
52 Week High
1,314.30
52 Week Low
888.90
PB Ratio
11.80
Debt to Equity
0.24
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from21 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+14.29 %
+14.29 %
Sell
Sell+19.05 %
+19.05 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Max Healthcare Institute Ltd. recorded a block trade worth ₹129.13 crores on the National Stock Exchange. The transaction involved approximately 1,158,151 shares traded at ₹1,115.00 per share.
neutral
Max Healthcare Institute Ltd. recorded a block trade worth Rs. 131.16 crores on the NSE. The transaction involved approximately 1,151,919 shares at a price of Rs. 1,138.60 per share.
neutral
Max Healthcare Institute Completes Rs. 85.40 Crore Block Trade on NSESep 23, 2025
Max Healthcare Institute executed a block trade worth Rs. 85.40 crores on the National Stock Exchange. The transaction involved approximately 740,138 shares at a price of Rs. 1,153.80 per share.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,137.90
#1 1,10,630.78
#8 92.29
#3 7,184.10
#1 28.68
#2 1,076
#5 30.34
45.32
7,674.00
1,10,340.35
70.04
#1 21,994.30
14.76
#1 1,505
39.78
53.29
1,055.40
79,678.28
86.10
7,849.70
13.25
809
#1 53.33
69.41
1,386.00
37,254.35
64.44
3,771.40
12.59
481
49.58
51.87
1,774.30
36,259.74
#1 46.21
5,575.00
12.29
790
-2.38
51.49
686.85
35,587.14
97.43
4,286.70
15.12
337
-98.18
61.52
707.35
28,303.83
78.50
3,067.00
21.98
415
-10.71
42.27
1,322.00
13,426.12
52.46
1,566.90
17.46
244
35.52
24.75
1,512.70
9,918.17
50.63
1,290.20
17.77
194
-1.57
59.64
664.00
9,362.41
250.21
2,257.70
17.03
49
-55.88
47.90

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
28.68 %
Net Income Growth
1.73 %
Cash Flow Change
30.10 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.75 %

Quarterly Financial Results

Quarterly Financials
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
270
285
278
275
276
691
835
831
1,026
1,050
1,023
964
1,098
1,163
1,186
1,255
1,326
1,409
1,381
1,468
1,578
1,748
1,902
1,957
2,064
Expenses
239
253
245
228
514
564
636
634
756
787
729
729
802
818
828
874
948
976
949
1,041
1,156
1,257
1,443
1,398
1,505
EBITDA
31
31
32
47
-239
127
200
197
270
262
293
235
296
345
359
381
379
433
432
427
422
491
459
559
559
Operating Profit %
9 %
10 %
8 %
8 %
-101 %
13 %
20 %
21 %
24 %
23 %
25 %
22 %
25 %
28 %
28 %
28 %
26 %
28 %
29 %
27 %
25 %
26 %
23 %
27 %
26 %
Depreciation
12
11
11
12
26
52
48
48
54
54
55
58
57
58
57
60
56
58
61
70
77
84
98
101
104
Interest
10
21
27
25
35
53
46
45
27
27
25
22
22
22
20
20
19
9
11
21
24
34
52
55
55
Profit Before Tax
9
-0
-6
10
-300
22
105
105
190
182
213
154
216
265
281
301
304
366
360
336
321
374
309
403
400
Tax
-0
1
-4
-43
14
6
15
35
43
37
23
31
44
-192
59
50
63
90
70
84
85
92
70
84
93
Net Profit
9
-1
-2
53
-314
17
90
70
147
145
190
124
173
457
222
251
240
277
289
252
236
282
239
319
308
EPS in ₹
0.17
-0.03
-0.03
0.91
-4.34
0.18
1.00
0.76
1.52
1.50
1.96
1.28
1.78
4.72
2.29
2.58
2.47
2.85
2.98
2.59
2.43
2.90
2.46
3.28
3.17

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,453
2,217
3,160
3,314
3,366
3,824
8,544
9,189
10,102
12,000
15,215
Fixed Assets
740
1,478
2,244
2,227
2,192
2,380
6,536
7,018
7,039
8,784
11,502
Current Assets
383
289
349
454
447
768
1,125
1,000
1,943
1,706
1,593
Capital Work in Progress
18
12
46
38
87
6
27
151
252
553
901
Investments
143
0
0
0
1
1
1
1
1
2
3
Other Assets
552
728
870
1,049
1,086
1,439
1,981
2,020
2,810
2,661
2,809
Total Liabilities
1,453
2,217
3,160
3,314
3,366
3,824
8,544
9,189
10,102
12,000
15,215
Current Liabilities
282
419
381
477
1,140
1,474
777
757
1,046
1,249
1,814
Non Current Liabilities
339
672
1,660
1,806
1,262
1,363
2,129
2,149
1,647
2,343
4,020
Total Equity
832
1,127
1,119
1,031
963
987
5,639
6,283
7,410
8,408
9,381
Reserve & Surplus
343
587
655
627
426
450
4,673
5,313
6,439
7,436
8,409
Share Capital
489
533
537
537
537
537
966
970
971
972
972

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
16
-40
4
-6
-2
267
516
-318
893
-395
-319
Investing Activities
-194
-364
-104
-124
-17
-127
206
-764
-102
-1,253
-1,614
Operating Activities
64
53
156
166
89
250
118
741
1,284
1,122
1,459
Financing Activities
145
271
-48
-48
-74
144
191
-294
-289
-264
-164

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
70.46 %
70.46 %
60.91 %
60.68 %
50.64 %
50.64 %
23.80 %
23.78 %
23.77 %
23.76 %
23.76 %
23.75 %
23.75 %
23.74 %
23.74 %
23.74 %
23.74 %
23.74 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.00 %
0.01 %
0.01 %
57.33 %
56.98 %
57.29 %
56.93 %
54.74 %
54.76 %
DIIs
4.86 %
7.93 %
8.70 %
15.60 %
17.49 %
19.26 %
21.00 %
20.47 %
19.35 %
11.90 %
11.32 %
11.34 %
14.96 %
15.36 %
15.14 %
15.55 %
17.58 %
17.42 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.18 %
5.76 %
5.20 %
5.23 %
5.41 %
4.94 %
4.54 %
4.36 %
3.72 %
3.54 %
3.55 %
3.34 %
3.29 %
3.24 %
3.18 %
3.13 %
3.31 %
3.42 %
Others
19.50 %
15.84 %
25.18 %
18.49 %
26.46 %
25.16 %
50.65 %
51.38 %
53.15 %
60.80 %
61.36 %
61.56 %
0.67 %
0.67 %
0.65 %
0.64 %
0.63 %
0.66 %
No of Share Holders
45,339
70,655
91,937
1,11,877
1,20,079
1,05,000
1,01,659
1,11,701
1,04,656
1,11,374
1,18,635
1,11,338
1,27,009
1,36,254
1,37,856
1,40,028
1,51,633
1,62,119

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1.5 1.5
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.14 0.13

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 Sept 2023 DIVIDEND Dividend
1.00 /share
08 Sept 2023 519.90 602.65
27 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2023 553.60 566.10
23 Aug 2024 DIVIDEND Dividend
1.50 /share
23 Aug 2024 835.15 869.30
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 882.75 984.55
05 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Nov 2024 994.50 1,036.60
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 1,082.95 1,025.90
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 1,159.90 1,187.10
04 Jul 2025 DIVIDEND Dividend
1.50 /share
04 Jul 2025 1,187.10 1,301.40
30 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2025 1,190.20 1,274.30
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 1,272.30 1,260.60

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201817 hours ago
Announcement under Regulation 30 (LODR)-Credit Rating5 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20117 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20158 days ago
Closure of Trading WindowSep 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 04, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Audio Recording Of Earnings Call Held On August 14 2025Aug 14, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 14, 2025
Agreement To Lease For Establishing A ~130 Bedded Built-To-Suit Hospital At Dehradun UttarakhandAug 13, 2025
Presentation On Earnings UpdateAug 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Board Meeting Outcome for Meeting Held On August 13 2025Aug 13, 2025
Results - Financial Results For Quarter Ended June 30 2025Aug 13, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Aug 12, 2025
Minutes Of 24Th Annual General MeetingAug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Board Meeting Intimation for Consideration And Approval Of Financial ResultsAug 06, 2025
Transcript Of 24Th Annual General MeetingAug 05, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 30, 2025
Summary Of Proceedings Of 24Th Annual General MeetingJul 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 15, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Reg. 34 (1) Annual Report.Jul 04, 2025
Notice Of 24Th Annual General Meeting And Integrated Annual Report For The Financial Year 2024-25Jul 04, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2025
Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source On Final DividendJun 24, 2025
Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source On Final DividendJun 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Audio Recording Of Earnings Call Held On May 21 2025May 21, 2025
Appointment Of Secretarial Auditor And Cost AuditorMay 20, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 20, 2025
Presentation On Earnings UpdateMay 20, 2025
Results For Quarter And Financial Year Ended March 31 2025May 20, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI Equity Hybrid Fund Direct Plan-Growth
0.00%
-7000000
-1.05%
-1.12%
Nippon India Growth Mid Cap Fund Direct- Growth
0.00%
-6300000
-1.89%
-2.03%
Kotak Midcap Fund Direct-Growth
0.00%
-5338730
-1.08%
-1.16%
Motilal Oswal Midcap Fund Direct-Growth
1.69%
-4392677
-1.52%
-2.01%
HSBC Midcap Fund Direct-Growth
0.00%
-4355000
-4.28%
-4.58%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.00%
-4139097
-1.87%
-2.02%
Invesco India Large & Mid Cap Fund Direct-Growth
0.00%
-3641271
-5.17%
-5.16%
PGIM India Midcap Fund Direct-Growth
0.00%
-3526055
-3.57%
-3.83%
Kotak Arbitrage Fund Direct-Growth
0.00%
-3214050
-0.51%
-0.43%
Axis Midcap Direct Plan-Growth
0.00%
-3039410
-1.13%
-1.32%
SBI Mid Cap Direct Plan-Growth
0.00%
-3000000
-1.57%
-1.66%
Edelweiss Mid Cap Direct Plan-Growth
0.00%
-2981836
-3.05%
-3.37%
Invesco India Mid Cap Fund Direct-Growth
0.00%
-2246434
-3.22%
-3.59%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
-2100000
-6.12%
-6.50%
Motilal Oswal Flexi Cap Fund Direct-Growth
0.00%
-1999900
-1.69%
-1.82%
Canara Robeco Large Cap Fund Direct-Growth
0.00%
-1938101
-1.37%
-1.47%
UTI Nifty 50 Index Fund Direct-Growth
0.73%
1603373
0.73%
0.73%
Sundaram Mid Cap Fund Direct-Growth
0.00%
-1553545
-1.43%
-1.54%
Canara Robeco Flexi Cap Fund Direct-Growth
0.00%
-1515998
-1.32%
-1.41%
HDFC Large and Mid Cap Fund Direct- Growth
0.00%
-1500000
-0.66%
-0.71%
Axis ELSS Tax Saver Direct Plan-Growth
0.00%
-1440012
-0.48%
-0.51%
HDFC NIFTY 50 Index Fund Direct -Growth
0.73%
1374668
0.73%
0.73%
Franklin India Mid Cap Fund Direct-Growth
0.00%
-1330021
-1.25%
-1.65%
HSBC Large and Mid Cap Fund Direct - Growth
0.00%
-1231700
-3.30%
-3.56%
PGIM India Flexi Cap Fund Direct-Growth
0.00%
-1213845
-2.25%
-2.41%

Technical Indicators

RSI(14)
Neutral
45.32
ATR(14)
Less Volatile
30.53
STOCH(9,6)
Neutral
31.36
STOCH RSI(14)
Neutral
63.83
MACD(12,26)
Bearish
-0.16
ADX(14)
Weak Trend
24.18
UO(9)
Bearish
51.29
ROC(12)
Downtrend And Accelerating
-3.64
WillR(14)
Neutral
-40.89

About Max Healthcare Institute

Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Chairperson NameAbhay Soi